USPTO 2015–2025 USPTO PatentsView US Corporation

Veritone Alpha, Inc.

USPTO PatentsView assignee record - 15 granted patents across 15 technology areas, recorded in grant years 2018–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G05B (Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements).

RSS updates for this company

The verdict

According to USPTO PatentsView, Veritone ranks #19,323 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 15 technology areas.

#19,323
of 49,997 US assignees by volume
Top 36%
by Innovation Score (40.3/100)
25.5
avg claims per patent
+50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19323 · US Corporation #19,323 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 15 grants
  • MID-PACK #19,323/49,997
  • PHOTO-FINISH Vascular Imaging
  • CPC-FOCUS G05B · 15 areas
  • INNOV-PAR 40.3/100
  • CLAIMS-DENSE 25.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +50% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Vascular Imaging Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Veritone’s 40.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Veritone

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Veritone's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Veritone?

Each dot is one of Veritone’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Veritone’s own 25.5 claims/patent is ABOVE the 16.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Veritone vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 14.914.91515.1 051015202530 Granted patents (volume) Avg claims / patent Vascular Imaging Corporation - 15, 15.07Vascular ImagingVaxxas Pty Limited - 15, 16.53Vaxxas PtyVedanta Biosciences, Inc. - 15, 15.47Vedanta Bioscienc…VentureMed Group, Inc. - 15, 17.47Venturemed GroupVerona Pharma PLC - 15, 17.27Verona PharmaVi-Jon, LLC - 15, 5.93Vi-jonVicarious FPC, Inc. - 15, 18.8Vicarious FPCVigilent Corporation - 15, 19.67VigilentVeritone Alpha, Inc. - 15, 25.53Veritone Alpha
Veritone vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Veritone's grants concentrate

Veritone Alpha, Inc. is a focused PatentsView assignee: 15 CPC subclasses with 93.3% of grants classified under G05B (Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2023. By volume, Veritone sits between Vascular Imaging Corporation and Vigilent Corporation.

Veritone's three-year grant acceleration

Veritone Alpha, Inc. shows 3 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Veritone's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Veritone holds 15 patents at rank #19,324, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Veritone

By rank, the assignees closest to #19,324 in granted patent volume.

Leaders in G05B (Control OR Regulating Systems IN General)

Other assignees with the most granted patents in Veritone's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Veritone, neither rank-band nor same-CPC leaders (those blocks stay above). In G05B (Control OR Regulating Systems IN General), Veritone ranks #332 of 3,455 assignees by patent count in that subclass.

Veritone's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 201820192020202120222023 1
USPTO utility patent grants by year · 2018–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Veritone Alpha, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 2 13.3%
2019 4 26.7%
2020 3 20.0%
2021 3 20.0%
2022 2 13.3%
2023 1 6.7%

Which technologies does Veritone Alpha, Inc. patent most?

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Veritone Alpha, Inc.'s patent record in context - here's where to go next.

  • Veritone Alpha, Inc.'s lead technology class is G05B (Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements), 93.3% of its portfolio - see every assignee active in that class. Explore G05B
  • Ranked #19,323 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Veritone Alpha, Inc. against Vascular Imaging Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 40.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.